Recombinant follicle-stimulating hormone in a patient hypersensitive to urinary-derived gonadotropins.
Hypersensitivity reactions are a documented complication of urinary-derived gonadotropin therapy. In this report, a patient allergic to these older products is successfully treated with recombinant follicle-stimulating hormone.